To test whether C/EBPβ and p53 could be co-deleted in pre-existing skin tumors, we generated skin tumors in Cre and DIKO mice using a DMBA/TPA tumorigenesis treatment protocol and treated with tamoxifen. The gene discussed is TP53; the disease is skin neoplasm.